Attorneys general from across the country have reached a sweeping, multibillion-dollar settlement with Purdue Pharma and the Sackler family over their marketing and distribution of opioids, state Attorney General Dave Sunday announced on Monday.
Pennsylvania could receive as much as $200 million from the $7.4 billion agreement with the makers of oxycontin, a prescription painkiller that “fueled a nationwide addiction epidemic,” Mr. Sunday’s office said in a statement.
The lawsuit could bring an end to a long-running legal saga between the Sackler family and Purdue Pharma over their role in pushing the drug into American communities through the decadeslong “rampant production and aggressive marketing of opioids,” the office said.
”As Pennsylvania families and communities suffered during an unprecedented addiction crisis, Purdue and the Sacklers reaped the mammoth profits from their products,” Mr. Sunday said in the statement.
The money would be parceled out to the state over 15 years, with most coming in just the first three.
“This monumental settlement achieves the top priority of getting as much money as quickly as possible to prevention, treatment, and recovery programs across the commonwealth,” Mr. Sunday said.
Read More
The settlement — which involved attorneys general from all 50 states, Washington, D.C. and U.S. territories — allows families of the victims of the opioid crisis to continue their own lawsuits against the Sackler family, a major change from a previous settlement that would have cut off those legal actions.
“For decades, the Sacklers put profits over people, and played a leading role in fueling the epidemic of opioid addictions and overdoses,” New York Attorney General Letitia James said. “While no amount of money can fully heal the destruction they caused, these funds will save lives and help our communities fight back against the opioid crisis.”
As part of the deal, the Sackler family will pay $6.5 billion and give up control over Purdue Pharma, the prosecutors announced.
Pennsylvania has also received $1.07 billion in opioid settlement funds from various other lawsuits, including those connected to McKesson, AmerisourceBergen, Cardinal Health, and Johnson & Johnson, according to public health nonprofit Vital Strategies, the Post-Gazette previously reported.
The Associated Press contributed.



Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.